Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells

被引:44
作者
Valerio, A
Ferrario, M
Martinez, FO
Locati, M
Ghisi, V
Bresciani, LG
Mantovani, A
Spano, P
机构
[1] Univ Brescia, Sch Med, Div Pharmacol, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy
[2] Univ Milan, Sch Med, Inst Gen Pathol, Milan, Italy
[3] Univ Brescia, IDET, Ctr Excellence Innovat Diagnost & Therapeut, Brescia, Italy
关键词
chemokines; human neurons; transcriptional profile; DNA array;
D O I
10.1002/jnr.20250
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Differentiated human NT2-N neurons were shown to express CCR5 and CXCR4 chemokine receptor mRNA and protein, and to be responsive to the chemokines CCL5 and CXCL12. Using cDNA microarray technology, CCL5 was found to induce a distinct transcriptional program, with reproducible induction of 46 and 9 genes after 2 and 8 hr of treatment, respectively. Conversely, downregulation of 20 and 7 genes was observed after 2 and 8 hr of treatment, respectively. Modulation of a selected panel of CCL5-responsive genes was also confirmed by quantitative RT-PCR and Western blot and compared to gene expression changes induced by CXCL12 treatment. Gene clustering identified distinct functional subsets of CCL5-responsive molecules, and a significant number of expressed sequence tags encoding unknown genes. CCL5-responsive genes comprise a significant number of enzymes, transcription factors, and miscellaneous molecules involved in neuronal survival and differentiation, including neurite outgrowth and synaptogenesis. Our results suggest that CCL5 biological functions might go beyond its recognized chemotactic activity in the central nervous system, in particular with regard to the control of neural plasticity events both during development and in postnatal life. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:371 / 382
页数:12
相关论文
共 52 条
[1]  
Andreasson Katrin I, 2002, Results Probl Cell Differ, V39, P113
[2]  
Angley C, 2003, J NEUROSCI, V23, P260
[3]   Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons [J].
Arakawa, Y ;
Bito, H ;
Furuyashiki, T ;
Tsuji, T ;
Takemoto-Kimura, S ;
Kimura, K ;
Nozaki, K ;
Hashimoto, N ;
Narumiya, S .
JOURNAL OF CELL BIOLOGY, 2003, 161 (02) :381-391
[4]   Chemokines in the CNS: plurifunctional mediators in diverse states [J].
Asensio, VC ;
Campbell, IL .
TRENDS IN NEUROSCIENCES, 1999, 22 (11) :504-512
[5]  
Bacon K, 2002, J INTERF CYTOK RES, V22, P1067
[6]   Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis [J].
Bacon, KB ;
Harrison, JK .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (01) :92-97
[7]   Characterization of chemokines and their receptors in the central nervous system: physiopathological implications [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1311-1329
[8]   Constitutive and inflammatory induction of α and β chemokines in human first trimester forebrain astrocytes and neurons [J].
Bakhiet, M ;
Mousa, A ;
Seiger, A ;
Andersson, J .
MOLECULAR IMMUNOLOGY, 2002, 38 (12-13) :921-929
[9]   Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator [J].
Bamforth, SD ;
Bragança, J ;
Eloranta, JJ ;
Murdoch, JN ;
Marques, FIR ;
Kranc, KR ;
Farza, H ;
Henderson, DJ ;
Hurst, HC ;
Bhattacharya, S .
NATURE GENETICS, 2001, 29 (04) :469-474
[10]   Chemokines in the brain: neuroimmunology and beyond [J].
Biber, K ;
Zuurman, MW ;
Dijkstra, IM ;
Boddeke, HWGM .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (01) :63-68